Cargando…

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

BACKGROUND: For the last year we have been treating normal responders with gonadotropins and letrozole during the whole stimulation in order to improve response to FSH by increasing the intrafollicular androgen concentration, and to reduce circulating estrogen concentrations. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haas, Jigal, Bassil, Rawad, Meriano, Jim, Samara, Nivin, Barzilay, Eran, Gonen, Noa, Casper, Robert F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577762/ https://www.ncbi.nlm.nih.gov/pubmed/28854933 http://dx.doi.org/10.1186/s12958-017-0288-8

Ejemplares similares

The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle
por: Haas, Jigal, et al.
Publicado: (2018)

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
por: Shapira, Moran, et al.
Publicado: (2020)

Predicting IVF outcome in poor ovarian responders
por: Lebovitz, Oshrit, et al.
Publicado: (2022)

Recent advances in in vitro fertilization
por: Casper, Robert, et al.
Publicado: (2017)

The effect of letrozole overlapped with gonadotropin on IVF outcomes in women with DOR or aged over 40 years old with repeated cycles
por: Li, Xiaojia, et al.
Publicado: (2023)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
por: Shim, Yoo Jin, et al.
Publicado: (2018)

Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU
por: Orvieto, Raoul, et al.
Publicado: (2022)

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2022)

A Study of Controlled Ovarian Stimulation with Clomiphene Citrate or Letrozole in Combination with Gonadotropins and IUI in Unexplained Infertility
por: Hembram, Madhusmita, et al.
Publicado: (2017)

Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT
por: Eftekhar, Maryam, et al.
Publicado: (2020)

Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study
por: D’Amato, Giuseppe, et al.
Publicado: (2018)

Effects of gonadotropin administration on clinical outcomes in clomiphene citrate‐based minimal stimulation cycle IVF
por: Karakida, Shinya, et al.
Publicado: (2019)

Future fertility of patients with zero oocytes yield in their first IVF cycle attempt
por: Orvieto, Raoul, et al.
Publicado: (2021)

Comparison of The Effectiveness of Clomiphene Citrate versus Letrozole in Mild IVF in Poor Prognosis Subfertile Women with Failed IVF Cycles
por: Oktem, Mesut, et al.
Publicado: (2015)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
por: Eftekhar, Maryam, et al.
Publicado: (2016)

Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF
por: Biasoni, Valentina, et al.
Publicado: (2011)

Comparing of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles
por: Akbari, Soheila, et al.
Publicado: (2012)

Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine Insemination
por: Yun, Bo Hyon, et al.
Publicado: (2015)

Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI
por: Dielen, C, et al.
Publicado: (2017)

GnRH Agonist vs. hCG for Triggering of Ovulation – Differential Effects on Gene Expression in Human Granulosa Cells
por: Haas, Jigal, et al.
Publicado: (2014)

Case Report of Ectopic Ovarian Pregnancy Following Fresh Embryo Transfer
por: Samara, Nivin, et al.
Publicado: (2016)

Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A randomized trial
por: Pourali, Leila, et al.
Publicado: (2017)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

The in-vitro effect of gonadotropins’ type and combination on Granulosa cells gene expressions
por: Yung, Yuval, et al.
Publicado: (2022)

Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination
por: Mitwally, Mohamed F, et al.
Publicado: (2004)

Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
por: Orvieto, Raoul, et al.
Publicado: (2021)

Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report
por: Haas, Jigal, et al.
Publicado: (2014)

Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages
por: Huang, Yan, et al.
Publicado: (2015)

Ovarian Hyper-Response to Administration of an GnRH-Agonist Without Gonadotropins
por: Park, Hyun Tae, et al.
Publicado: (2011)

Predictor for supraphysiologic serum estradiol elevation on hCG triggering day of controlled ovarian stimulation using letrozole and gonadotropins in women with estrogen-dependent cancers
por: Kim, Sung Woo, et al.
Publicado: (2020)

Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF
por: Nakao, Kazuki, et al.
Publicado: (2021)

Genetic Variants of Gonadotropins and Their Receptors Could Influence Controlled Ovarian Stimulation: IVF Data from a Prospective Multicenter Study
por: Alviggi, Carlo, et al.
Publicado: (2023)

Co-treatment of gonadotropin and letrozole in infertile women with endometriosis: A double-blind randomized clinical trial
por: Ebrahimi, Mahbod, et al.
Publicado: (2022)

Apolipoprotein B is regulated by gonadotropins and constitutes a predictive biomarker of IVF outcomes
por: Scalici, Elodie, et al.
Publicado: (2016)

Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women
por: Hsu, Chao-Chin, et al.
Publicado: (2022)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome
por: Chen, Yilu, et al.
Publicado: (2018)

Comparison of letrozole with gonadotropin-releasing hormone agonist in frozen embryo transfer after recurrent implantation failure: An RCT
por: Khadem Ghaebi, Nayere, et al.
Publicado: (2020)

The Success of Ovulation Induction with Letrozole and Gonadotropins in Obese and Nonobese Women: A Study from a Tertiary Center
por: Gowri, Vaidyanathan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bkpg1lhqej55648q4dl5vbb3ju